1. Home
  2. REPL vs BALY Comparison

REPL vs BALY Comparison

Compare REPL & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.24

Market Cap

781.3M

Sector

Health Care

ML Signal

HOLD

Logo Bally's Corporation

BALY

Bally's Corporation

HOLD

Current Price

$16.04

Market Cap

651.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
BALY
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
781.3M
651.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
REPL
BALY
Price
$7.24
$16.04
Analyst Decision
Buy
Hold
Analyst Count
9
5
Target Price
$12.00
$15.40
AVG Volume (30 Days)
1.4M
79.9K
Earning Date
02-11-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,490,807,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
N/A
$6.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.36
52 Week Low
$2.68
$8.46
52 Week High
$14.80
$22.41

Technical Indicators

Market Signals
Indicator
REPL
BALY
Relative Strength Index (RSI) 28.73 44.37
Support Level $6.77 $16.06
Resistance Level $9.41 $17.24
Average True Range (ATR) 0.55 0.91
MACD -0.19 -0.07
Stochastic Oscillator 11.96 22.82

Price Performance

Historical Comparison
REPL
BALY

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About BALY Bally's Corporation

Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.

Share on Social Networks: